SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-20-014995
Filing Date
2020-08-07
Accepted
2020-08-07 18:48:03
Documents
6
Period of Report
2020-08-07
Effectiveness Date
2020-08-10

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 337024
2 image_001.jpg GRAPHIC 5987
3 image_002.jpg GRAPHIC 14580
4 logo_001.jpg GRAPHIC 14580
5 proxy_001.jpg GRAPHIC 473965
6 proxy_002.jpg GRAPHIC 405814
  Complete submission text file 0001493152-20-014995.txt   1598858
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12830 | Film No.: 201085946
SIC: 2836 Biological Products, (No Diagnostic Substances)